EMEA-000733-PIP02-12
Key facts
| Invented name |
|
| Active substance |
strontium succinate
|
| Therapeutic area |
Immunology-Rheumatology-Transplantation
|
| Decision number |
P/0022/2013
|
| PIP number |
EMEA-000733-PIP02-12
|
| Pharmaceutical form(s) |
|
| Condition(s) / indication(s) |
Treatment of osteoporosis
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Les Laboratoires Servier
|
| Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|